Clinical Trials Directory

Trials / Completed

CompletedNCT07458828

Evaluate the Efficacy and Safety of Hydrolyzed Keratin Peptide Powder on Hair Health

Oral Hydrolyzed Keratin Peptide Powder Improves Hair Quality and Scalp Barrier Function: A 24-Week Randomized, Double-Blind, Placebo-Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
120 (actual)
Sponsor
Dong-A Pharmaceutical · Industry
Sex
All
Age
19 Years – 60 Years
Healthy volunteers
Accepted

Summary

This study is designed to evaluate the efficacy and safety of Hydrolyzed Keratin Peptide Powder in promoting hair health in adult with mild to moderate hair damage, compared to a placebo control.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTDAP-HAI-403Each subject takes two capsules per day for 24 weeks. Each capsule contains DAP-HAI-403 250mg.
DIETARY_SUPPLEMENTPlaceboEach subject takes two capsules per day for 24 weeks.

Timeline

Start date
2024-01-23
Primary completion
2025-01-21
Completion
2025-08-12
First posted
2026-03-09
Last updated
2026-03-09

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT07458828. Inclusion in this directory is not an endorsement.

Evaluate the Efficacy and Safety of Hydrolyzed Keratin Peptide Powder on Hair Health (NCT07458828) · Clinical Trials Directory